Based on 9 attributed questions from 2 Morningstar analyst(s) across 1 NZX-listed company, 2018-05 → 2021-11. Counts only.
Sourced from public NZX filings, our database, and questions people ask about Morningstar.
Morningstar is an independent research firm, not a brokerage. According to our records, Morningstar provides equity analysis and valuation research rather than executing trades or offering brokerage services. Their NZX coverage includes fair value estimates, moat ratings, and uncertainty assessments for select listed companies.
Based on our data, Morningstar covers 2 NZX-listed companies with independent equity analysis. Their research team includes 2 analysts focused on providing non-broker perspectives on company valuations for the New Zealand market.
Morningstar star ratings reflect their analysts' assessment of a company's valuation relative to fair value estimates. A higher star rating indicates the stock is priced lower relative to estimated fair value, but star ratings are analytical opinions and should not be interpreted as buy or sell signals. Investors should conduct their own analysis alongside Morningstar research.
Morningstar provides independent research on NZX companies, including fair value estimates and moat ratings—assessments of competitive advantages. This research represents an alternative to traditional broker-affiliated analysis, offering a non-conflicted perspective on select listed companies' valuations.
Morningstar offers some research content freely through their website (morningstar.com), though comprehensive coverage and detailed equity reports typically require a subscription. For specific details on free versus paid NZX research access, you can visit their website directly.
Morningstar's research on NZX companies is available through their main website. You can also view their NZX analyst coverage and research summaries on NZXplorer, which aggregates independent research on New Zealand listed companies.
Morningstar includes uncertainty assessments in their equity analysis for NZX companies, helping investors understand the range of possible outcomes in their valuations. This approach acknowledges that fair value estimates contain inherent uncertainty rather than presenting a single definitive price target.
